This one creates a smooth barrier on your skin that locks in moisture and makes everything feel silky
Benefits & Considerations Potential Benefits: Greater weight loss efficacy than single-agent GLP-1s Enhanced satiety and appetite control Reduced caloric intake without stimulant side effects Possible benefits on glucose regulation and lipids Considerations: Still experimental not yet available for clinical use May share similar GI side effects (nausea, fullness, constipation) Requires ongoing injection therapy for maintenance The Future of Multi-Hormone Obesity Therapy If current trials continue to show success, cagrilintide-based combinations could usher in a new generation of multi-agonist weight-loss medicationssimilar to how tirzepatide built on semaglutides success by adding GIP activity
S., Manninen, M., & Egan, B
Furthermore, they serve as vehicles for the delivery of protective microRNAs and proteins, which in turn enhance TJ protein expression and barrier resilience [252, 253]
The idea of using very low, or micro, doses of GLP-1 agonists is intriguing